Hospital-Acquired Disease Testing Market to 2027 - Meridian Bioscience, Nordion, Cantel Medical, Thermo Fisher Scientific, Diatherix Eurofins, QIAGEN, Cepheid, Clinical Lab Products, and McKesson Medical-Surgical

The hospital-acquired disease testing market report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.

The global hospital-acquired disease testing market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market..

Get PDF sample copy of this Study: https://www.theinsightpartners.com/sample/TIPBT00002662/

Hospital acquired infections are caused due to viral, fungal and bacterial pathogens. A nosocomial infection also referred to as hospital-acquired infections occurs because of an infectious agent or toxin that exists in certain location of a medical facility. One of the most common wards where HAIs occur is the intensive care unit (ICU), where doctors treat serious diseases. Hospital-acquired diseases continue to be a major concern for healthcare industry.

The market for hospital-acquired disease testing market is expected to witness growth due to increasing number of patients suffering with hospital-acquired infections. Moreover, advancing healthcare infrastructures with introduction of infection surveillance solutions and systems suggesting risks and action plans to manage these diseases are further expected to drive the growth of the market. However, inadequate security in healthcare facilities and lack of funding in developing and under-developed economies are likely to hinder hospital-acquired disease testing market growth.

The key players influencing the market are Thermo Fisher Scientific Inc., Diatherix Eurofins, LLC, QIAGEN, Meridian Bioscience, Inc., Nordion (Canada) Inc., F. Hoffmann La Roche Ltd, Cantel Medical, Cepheid, Clinical Lab Products, and McKesson Medical-Surgical Inc. among others.

The global hospital-acquired disease testing market is segmented on the basis of test type and end user. On the basis of test type, the global hospital-acquired disease testing market is segmented into UTI tests, SSI tests, pneumococcal infection tests, bloodstream infection tests, and MRSA tests. Based on end user, the hospital-acquired disease testing market is segmented into hospitals, clinics, ambulatory surgical centers, and community health centers.

Buy the complete report with Comprehensive table of contents @ https://www.theinsightpartners.com/buy/TIPBT00002662/

The hospital-acquired disease testing market report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global hospital-acquired disease testing market based test type and end user. It also provides market size and forecast till 2027 for overall hospital-acquired disease testing market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com
Web: https://www.theinsightpartners.com/

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

This release was published on openPR.